评价 Fortetropin 在老年和行动不便的老年犬中的作用。
Evaluation of Fortetropin in geriatric and senior dogs with reduced mobility.
机构信息
Department of Clinical Sciences College of Veterinary Medicine, Kansas State University, Manhattan, Kansas 66506, USA.
出版信息
Can Vet J. 2022 Oct;63(10):1057-1060.
As pets age, quality of life and mobility can be affected by pain of osteoarthritis and age-related muscle atrophy (sarcopenia). The purpose of this randomized, double-blinded, placebo-controlled study was to evaluate the effects of Fortetropin, a nonthermal-pasteurized, freeze-dried, fertilized egg yolk product, on mobility in senior dogs. Mobility scores were calculated using a standardized and validated client-based survey: the Liverpool Osteoarthritis in Dogs (LOAD) questionnaire. Results showed mild, but statistically significant, improvement of the mobility scores for the treatment group at both week 6 ( = 0.03) and week 12 ( = 0.006) compared to the baseline score. No statistical improvement was noted at any time in the placebo group or between the treatment and placebo group.
随着宠物年龄的增长，骨关节炎引起的疼痛和与年龄相关的肌肉萎缩（肌少症）会影响其生活质量和行动能力。本项随机、双盲、安慰剂对照研究的目的是评估 Fortetropin（一种非热巴氏灭菌、冻干、受精鸡蛋黄产品）对老年犬行动能力的影响。使用标准化和经过验证的基于客户的调查（即利物浦犬骨关节炎（LOAD）问卷）来计算行动能力评分。结果显示，与基线评分相比，治疗组在第 6 周（ = 0.03）和第 12 周（ = 0.006）时的行动能力评分有轻度但具有统计学意义的改善。在任何时候，安慰剂组或治疗组与安慰剂组之间均未观察到统计学上的改善。
Zotero 插件